What is Damora Therapeutics, Inc. (DMRA) stock price today?

Damora Therapeutics, Inc. (DMRA) currently trades at $25.36 per share. The stock has a market capitalization of $1.46B and a P/E ratio of —x.

Is DMRA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Damora Therapeutics, Inc. has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

DMRA

Damora Therapeutics, Inc.

NASDAQ: DMRA · HEALTHCARE · BIOTECHNOLOGY

$25.36

-1.17% today

Updated 2026-05-01

Market cap

$1.46B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.98

Dividend yield

—

52W range

$2 – $38

Volume

0.3M

Market cap

$1.46B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.98

Dividend yield

—

52W range

$2 – $38

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$45.17

+78.12%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $566000.00 — positive

Risks

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-61.62M	$-38.35M	$-21.44M	$-209.84M	$-200.74M
EPS	—	—	—	—	$-3.98
Free cash flow	$-43.13M	$-36.91M	$-18.62M	$-6.73M	$566000.00
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DMRA	$1.46B	17	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-41.61%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.35%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Damora Therapeutics, Inc. trades at $25.36. Our Smart Value Score of 17/100 indicates the stock is weak.

Frequently asked questions

What is Damora Therapeutics, Inc.'s stock price?

Damora Therapeutics, Inc. (DMRA) trades at $25.36.

Is Damora Therapeutics, Inc. overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of Damora Therapeutics, Inc. (DMRA)?

The analyst target price is $45.17, representing +78.1% upside from the current price of $25.36.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-163.80%

Beta1.60

50D MA$26.46

200D MA$16.80

Shares out0.06B

Float0.04B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DMRA vs LLY →DMRA vs JNJ →DMRA vs ABBV →Stock screener →